BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//CTMSS - ECPv6.7.0//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://clinicaltmssociety.org
X-WR-CALDESC:Events for CTMSS
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20240101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=UTC:20240402T080000
DTEND;TZID=UTC:20240402T210000
DTSTAMP:20260910T145502
CREATED:20241017T011237Z
LAST-MODIFIED:20260506T160410Z
UID:1184-1712044800-1712091600@clinicaltmssociety.org
SUMMARY:Electroconvulsive Therapy: How to Make a Highly Effective Treatment More Acceptable
DESCRIPTION:> > Register Now <<\nElectroconvulsive therapy (ECT) is a highly effective treatment for major depression.  However\, it is underused due to stigma and concern over its side effects on memory.  This webinar will describe the history of ECT including its many improvements over more than 80 years. This will be followed by a presentation of recent research that aims to make ECT more acceptable by minimizing its side effects on memory through better understanding of the mechanisms of its therapeutic effect on depression and its adverse effects on memory. \nAt the end of this presentation participants will: \n\nBe familiar with the history of ECT including its improvements over more than 80 years.\nBe aware of the therapeutic effect of ECT on major depression and the adverse effect of ECT on memory.\nLearn of new research into the mechanisms of the therapeutic and adverse effects of ECT that aims to make ECT more acceptable by minimizing its side effects on memory.\n\n1 Hour CME Credit Available \nFormat: Webinar \nCost: Members: $25 | Non-members $50 | Student Members FREE \nSpeaker: William T. Regenold\, MDCM \n \nWilliam T. Regenold\, MDCM is a board certified general and geriatric psychiatrist.  He is a Senior Research Physician and the Medical Director of the Noninvasive Neuromodulation Unit (NNU) in the Experimental Therapeutics and Pathophysiology Branch of the National Institute of Mental Health (NIMH).  At the NIMH\, he collaborates with a research team investigating electroconvulsive therapy and transcranial magnetic stimulation\, primarily in the treatment of major depression. Dr. Regenold studied medicine at McGill University in Montreal.  He trained in Medicine\, Neurology and Psychiatry at the Johns Hopkins Bayview Medical Center in Baltimore and in Psychiatry and Old Age Psychiatry at the Johns Hopkins Hospital in Baltimore and the Maudsley Hospital in London. Prior to joining the NIMH\, he was at the University of Maryland Department of Psychiatry where he was Director of the Division of Geriatric Psychiatry\, the Adult Inpatient Service\, and the Electroconvulsive Therapy Service.  His research at the University of Maryland focused on mood disorder pathophysiology and electroconvulsive therapy. \n> > Register Now <<
URL:https://clinicaltmssociety.org/event/electroconvulsive-therapy-how-to-make-a-highly-effective-treatment-more-acceptable/
CATEGORIES:All Events,Grand Rounds Webinar
END:VEVENT
END:VCALENDAR